# DNV supports FAMID Biomedical Technology in achieving IVDR certification for its Class C IVD in six months

- Link: https://www.thailand-business-news.com/pr-news/dnv-supports-famid-biomedical-technology-in-achieving-ivdr-certification-for-its-class-c-ivd-in-six-months
- Published: 2026-11-19T08:00:00+07:00
- Author: PR Newswire

|   |

_Certification supports European market access for_ _a diagnostic test designed 
to aid the diagnosis of cervical precancerous lesions._

HOVIK, Norway, Nov. 19, 2026 /PRNewswire/ — DNV, an EU Notified Body for the In 
Vitro Diagnostic Medical Devices Regulation (IVDR), has issued an IVDR certificate
to FAMID Biomedical Technology (Tianjin) Co., Ltd for its diagnostic test designed
to support the early detection of cervical cancer.

 [⌊Certificate handover following IVDR certification of FAMID Biotech’s E7 Oncoprotein Rapid Test Kit.⌉](https://mmx.prnasia.com/media/MS2038682/20261118044713EST_image_1.jpg?id=OA3088499&p=medium600)

Certificate handover following IVDR certification of FAMID Biotech’s E7 Oncoprotein
Rapid Test Kit.

The certification was completed in just six months, following assessment of the 
manufacturer’s quality management system, clinical evidence and technical documentation.

FAMID Biomedical’s newly certified E7 Oncoprotein Rapid Test Kit, classified as 
a Class C in vitro diagnostic medical device under the IVDR, is designed as an aid
in the diagnosis of cervical epithelial cell lesions through the detection of HPV
E7 oncoprotein in cervical cell samples. The product is intended for both professional
laboratory use and self-testing.

While every conformity assessment is different, the project demonstrates what can
be achieved when a manufacturer enters the process well prepared.

Jim Miao, _CEO of FAMID Biomedical Technology_ said:

"Bringing medical technologies to market requires not only strong technical capabilities,
but also a certification partner who understands the importance of timely market
access. Working with DNV has been a highly positive experience. Their professionalism,
technical expertise and collaborative approach gave us confidence throughout the
certification process and helped us progress efficiently towards bringing our technology
to market. For our business, having a reliable and responsive partner is invaluable
as we continue to develop our business and expand into new markets."

Cecilie Gudesen Torp, _Managing Director of Medical Technologies, Life Sciences_
at DNV commented:

"Achieving IVDR certification just six months after contract signing is a significant
achievement and reflects both FAMID Biomedical Technology’s preparation and the 
expertise and close coordination of our teams throughout the assessment process.
IVDR places significantly greater requirements on many diagnostic manufacturers,
and this project demonstrates what can be achieved when strong preparation, specialist
expertise and effective project management come together. Most importantly, the 
certification supports FAMID Biomedical Technology in bringing its diagnostic technology
to the European market."

DNV has built specialist IVDR competence and capacity across its global Medical 
Technologies organisation to support manufacturers navigating these requirements
and is working with a growing portfolio of IVD manufacturers globally, combining
local customer engagement with specialist regulatory and technical expertise across
its international organization.

 

 [⌊FAMID Biotech’s E7 Oncoprotein Rapid Test Kit and its testing components.⌉](https://mmx.prnasia.com/media/MS2038683/20261118044713EST_image_2.jpg?id=OA3088500&p=medium600)

FAMID Biotech’s E7 Oncoprotein Rapid Test Kit and its testing components.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [DNV supports FAMID Biomedical Technology in achieving IVDR certification for its Class C IVD in six months ](https://en.prnasia.com/story/archive/5099722_AE99722_0?rand=184833)
